Patent details

Basic Information

Publication number:

91650

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP019183839

Legal Status:

Expired

Application number:

91650

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/09/545/001-010 - Onglyza-saxagliptin

Marketing Authorization Type:

Marketing Authorization Date:

05/10/2009

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

17/02/2010

First Marketing Authorization date:

05/10/2009

Grant date:

19/04/2010

Activation date:

05/03/2021

Publication date:

19/04/2010

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

05/10/2024

SPC Extension Expiration:

05/10/2024

Rejection date:

Withdrawal date:

Owner

From:

08/04/2014

 

 

Name:

ASTRAZENECA AB

Address:

VÄSTRA MÄLAREHAMNEN 9, 151 85, SÖDERTÄLJE, Sweden (SE)

History of Owners

From:

17/02/2010

To:

07/04/2014

Name:

Bristol-Myers Squibb Company

Address:

P.O. Box 4000, Lawrenceville-Princeton Road, Princeton, NJ 08543-4000, United States (US)

Agent

Name:

MARKS & CLERK LLP

From:

17/02/2010

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

SULSKY Richard, B.

Address:

United States (US)

2

Name:

ROBL Jeffrey, A.

Address:

United States (US)

3

Name:

BETEBENNER David, A.

Address:

United States (US)

4

Name:

HAMANN Lawrence, G.

Address:

United States (US)

5

Name:

MAGNIN David, R.

Address:

United States (US)

6

Name:

AUGERI David, J.

Address:

United States (US)

Publication

Bulletin

1

Bulletin Heading:

SPC4

Bulletin edition number:

2019/02

Publication date:

22/02/2019

Description:

Section F : Correction of granted supplementary protection certificates – I9 publication

2

Bulletin Heading:

SPC3

Bulletin edition number:

2021/05

Publication date:

13/04/2021

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

27/02/2024

Last Annual Fee Paid Number:

24

Last Annual Fee Paid Amount:

440 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
22/12/2016	Incoming Correspondence (Post)	18
03/01/2019	Outgoing Correspondence	1
03/01/2019	Publication	1
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56